Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick pickspolarean Share News (POLX)

Share Price Information for polarean (POLX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.75
Bid: 3.70
Ask: 3.80
Change: -0.05 (-1.32%)
Spread: 0.10 (2.703%)
Open: 3.80
High: 3.80
Low: 3.75
Prev. Close: 3.80
POLX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Ocean Wilsons annual profit slips; dividend unchanged

Mon, 15th Mar 2021 19:07

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

----------

Ocean Wilsons Holdings Ltd - Bermuda-based investment company operating a maritime services company in Brazil - Posts pretax profit for 2020 of USD74.6 million, slipping 9.6% from USD82.5 million the year prior. Revenue decreases 13% to USD352.8 million from USD406.1 million. Proposed dividend of 70 US cents per share, unchanged from year prior. Says 2021 is looking more optimistic as the vaccine roll-out programme starts in earnest, and the blend of better growth together with still abundant liquidity should serve to underpin risk assets. Says it sees little reason to deviate from its positive stance on equities and more cautious view on bonds.

----------

Nightcap PLC - bar operator in the UK - Posts pretax loss of GBP318,342 from September 23, 2020 to December 31, 2020. Nightcap was incorporated on September 23 last year and was admitted to trading on the AIM market of the London Stock Exchange in January this year. "Nightcap has been set up to acquire, re-capitalise and develop drinks-led concepts with significant potential across the UK. The impact of the Covid-19 pandemic on the hospitality industry has been immense and we are well-placed to support entrepreneurs and businesses that have suffered during the pandemic," says Nightcap.

----------

Diaceutics PLC - Belfast-based precision medicine diagnostics firm - Swings to pretax loss in 2020 of GBP682,000 from GBP497,000 profit a year prior. Administrative expenses increase 19% to GBP10.0 million from GBP8.4 million. Revenue falls 5.2% to GBP12.7 million from GBP13.4 million. Does not pay dividend for the year, following suit to the prior year. Says it will not be reviewing its dividend policy given its results for the year.

----------

Dunedin Enterprise Investment Trust PLC - invests in UK lower mid-market management buyouts - Posts net asset value per share at December 31 of 413.9 pence, down 6.9% from 444.4p a year prior. Says the trading performance of the portfolio was impacted by coronavirus and the resulting disruption to economic activity. Proposes final dividend of 2.0 pence per share, down 60% from 5.0p. Says although the disruption created by the pandemic has continued to be the main focus for portfolio companies during the year, the generally strong financial position of portfolio companies has provided "some" protection.

----------

Octopus Renewables Infrastructure Trust PLC - London-based investor in mainly onshore wind and solar projects - Posts net asset value per share of 98.3 pence at December 31 following its IPO a year prior. Achieves dividend target of 3.18 pence per share and reconfirms its dividend target for 2021 of 5p per share. "I am delighted to announce our good performance and the publication of ORIT's first annual report. In a period which has been dominated by Covid-19, it is pleasing to reflect on the considerable achievements of the company to date," says Chair Phil Austin.

----------

Thor Mining PLC - Australia-focused exploration and development company - Posts pretax loss for the half year ended December 31 of GBP397,000, narrowing 17% from GBP479,000 a year prior. Swings to a profit on the sale of investments of GBP222,000 from GBP28,000 loss the year before. Says it has numerous developments planned for the rest of the year including a maiden drilling program for gold at Ragged Range, set for the June quarter, and an initial drill program at Colorado for uranium and vanadium expected in May.

----------

Maven Income & Growth VCT 5 PLC - investment trust managed by London-based Maven Capital Partners - Posts net asset value per share at November 30 of 36.38 pence per share, down2.6% from 37.37p per share a year prior. NAV total return for 2020 lifted 0.8% to 79.83p from 79.22p a year prior. Says that, under the circumstances, the company's directors consider this to be a "creditable performance", which reflects the "strength and diversity of the underlying portfolio and the ability of most investee companies to adjust to the current market conditions". Proposes final dividend of 1.10 pence per share. Notes the uncertainties posed by Brexit and Covid-19 going forward.

----------

Allianz Technology Trust PLC - London-based technology trust - Posts net asset value per share at December 31 of 2,913.1 pence, rising 76% from 1,654.1 pence a year prior. Says it saw an excellent year in 2020 thanks to the technology sector soaring in value. Proposes no dividend for 2020, unchanged from the year prior. Says that although technology stocks have become "a much more mainstream choice", the fund still believes that it has advantages "since the portfolio offers risk-diversification by investing in a basket of stocks across a range of tech sub-sectors, carefully balancing risks and opportunities."

----------

Polarean Imaging PLC - London-based medical‑imaging technology - Proposes placing to raise a minimum of GBP17.54 million shares. Says imaging provider Bracco Imaging Spa, which owns a 7.5% stake in the company, will subscribe to GBP2.5 million worth of shares. Says around GBP220,000 will be subscribed to by company directors. Says up to a further GBP2.0 million will be raised through the issue of up to approximately 3.3 million shares in an open offer. Says the proceeds will go to extending "its cash runway for at least" 18 months.

----------

Mountfield Group PLC - AIM cash shell - Will be removed from the FTSE AIM All-Share Index on Thursday.

----------

Horizonte Minerals PLC - nickel company focused on Brazil - Says that, as part of a review from its auditors, adjustments have been made to its results for the three and nine months ended September 30. Says the key adjustment is the result of a new accounting policy adopted regarding the capitalisation of borrowing costs due to the interest charge on the royalty financing arrangement between the company and Orion Mine Finance. Says one of the adjustments have a cash impact and the net result is a GBP2.3 million reduction in losses and subsequent GBP2.3 million increase in net assets. In 2019, the company completed a USD25 million royalty transaction with Orion Mine Finance. Orion provided USD25 million of cash upfront in return for a 2.25% royalty on the Araguaia ferro-nickel project in Brazil.

----------

Pembroke VCT PLC - early stage investor in leisure and luxury brands - Says it will use the over-allotment facility of GBP20 million in relation to its subscription offer, effectively doubling the amount that can be raised to GBP40 million.

----------

By Greg Roxburgh; gregroxburgh@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
16 Apr 2024 20:16

TRADING UPDATES: Nexteq confident of meeting full-year expectations

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
29 Feb 2024 14:28

Polarean Imaging shares sink after announcing a costly strategic plan

(Alliance News) - Polarean Imaging PLC shares dropped on Thursday, after the company said it would need to find an additional USD10 million to finance its medium-term ambitions.

Read more
15 Jan 2024 11:21

IN BRIEF: Polarean Imaging strategic parter raises stake to above 10%

Polarean Imaging PLC - London-based developer of medical imaging devices providing magnetic resonance imaging of the lungs - Strategic partner NUKEM Isotopes GmbH buys 9.5 million Polarean shares from Amati Global Investors Ltd, raising its stake to 10.5% from 6.1%. Alzenau, Germany-based NUKEM is a trading company in stable isotopes and noble gases. Amati retains a 4.6% stake in Polarean, down from its last reported level of 9.8%. The shares purchased by NUKEM are worth GBP725,800 at Polarean's current market price.

Read more
7 Dec 2023 16:01

Polarean gets first de novo order for Xenoview polariser

(Sharecast News) - Lung-focussed MRI technology developer Polarean Imaging said in an update on Thursday that it has received its first de novo order for a new Xenoview polariser.

Read more
7 Dec 2023 12:14

IN BRIEF: Polarean shares jump on Xenoview polariser order

Polarean Imaging PLC - London-based medical imaging technology developer - Receives its first de novo order for a new Xenoview polariser from an unnamed "top-tier" academic medical centre located in the northeast of the US. Polarean says it continues to have positive meetings and is in active negotiations with additional academic medical centres. Xenoview is a hyperpolarised contrast agent for use with magnetic imaging for the evaluation of lung ventilation in adults and paediatric patients aged 12 years and older. It was approved for use in the US last year.

Read more
7 Dec 2023 11:11

AIM WINNERS & LOSERS: Smart Metering accepts offer; order for Polarean

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Thursday.

Read more
8 Sep 2023 14:12

Polarean Imaging enters strategic partnership with VIDA Diagnostics

(Sharecast News) - Advanced MRI technology specialist Polarean Imaging announced a strategic partnership with a clinical imaging intelligence company VIDA Diagnostics on Friday.

Read more
8 Sep 2023 10:27

Polarean Imaging partners with Vida Diagnostics on MRI solutions

(Alliance News) - Polarean Imaging PLC on Friday said that it has partnered with Vida Diagnostics Inc to work on advanced magnetic resonance imaging solutions for the lungs.

Read more
7 Sep 2023 14:26

TRADING UPDATES: Polarean withdraws commercial targets on revenue drop

(Alliance News) - (Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
7 Sep 2023 11:20

AIM WINNERS & LOSERS: CVS plunges on CMA vet probe; Angle ascends

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Thursday.

Read more
5 Sep 2023 19:42

IN BRIEF: Polarean Imaging announces code price range for Xenoview

Polarean Imaging PLC - London-based medical imaging technology developer - Announces that following statement on August 29, the reimbursement code for the Polarean Xenoview technology has been assigned to a new technology ambulatory payment classification code which corresponds to a payment range of between USD1,201 to USD1,300 as part of the 2023 medicare hospital outpatient prospective payment system final rule. Notes the codes enables healthcare providers a path to bill for "magnetic resonance imaging with inhaled hyperpolarised xenon-129 contrast agent, chest, including preparation and administration of agent."

Read more
31 Aug 2023 15:52

UK earnings, trading statements calendar - next 7 days

Friday 1 September 
Diversified Energy Co PLCHalf Year Results
Monday 4 September 
Ashtead Technology Holdings PLCHalf Year Results
Belvoir Group PLCHalf Year Results
Tuesday 5 September 
Alumasc Group PLCFull Year Results
Ashtead Group PLCQ1 Results
Blackbird PLCHalf Year Results
Craneware PLCFull Year Results
DS Smith PLCTrading Statement
Ecora Resources PLCHalf Year Results
Eurocell PLCHalf Year Results
Gamma Communications PLCHalf Year Results
GetBusy PLCHalf Year Results
Headlam Group PLCHalf Year Results
Johnson Service Group PLCHalf Year Results
Luceco PLCHalf Year Results
Michelmersh Brick Holdings PLCHalf Year Results
Midwich Group PLCHalf Year Results
Pebble Group PLCHalf Year Results
Shearwater Group PLCFull Year Results
SigmaRoc PLCHalf Year Results
STV Group PLCHalf Year Results
Tissue Regenix Group PLCHalf Year Results
Wednesday 6 September 
Apax Global Alpha LtdHalf Year Results
Ashmore Group PLCFull Year Results
Bakkavor Group PLCHalf Year Results
Barratt Developments PLCFull Year Results
Darktrace PLCFull Year Results
Halfords Group PLCTrading Statement
Hochschild Mining PLCHalf Year Results
M Winkworth PLCHalf Year Results
Malin Corp PLCHalf Year Results
Nexteq PLCHalf Year Results
Oxford Nanopore Technologies PLCHalf Year Results
Restaurant Group PLCHalf Year Results
WH Smith PLCTrading Statement
Thursday 7 September 
Angle PLCHalf Year Results
Beazley PLCHalf Year Results
Cairn Homes PLCHalf Year Results
Currys PLCTrading Statement
Direct Line Insurance Group PLCHalf Year Results
Energean PLCHalf Year Results
Funding Circle Holdings PLCHalf Year Results
Genus PLCFull Year Results
Hilton Food Group PLCHalf Year Results
Inspecs Group PLCHalf Year Results
International Public Partnerships LtdHalf Year Results
Lords Group Trading PLCHalf Year Results
Melrose Industries PLCHalf Year Results
Mpac Group PLCHalf Year Results
Playtech PLCHalf Year Results
Polarean Imaging PLCHalf Year Results
Safestore Holdings PLCTrading Statement
Synthomer PLCHalf Year Results
Vistry Group PLCHalf Year Results
WAG Payment Solutions PLCHalf Year Results
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
29 Aug 2023 14:22

Polarean's Xenoview gets US reimbursement code

(Sharecast News) - Medical device developer Polarean Imaging announced on Tuesday that its Xenoview technology has been granted a new reimbursement code by the US Centers for Medicare and Medicaid Services (CMS).

Read more
29 Aug 2023 11:36

IN BRIEF: Polarean Imaging product cleared for US Medicare payments

Polarean Imaging PLC - London-based medical imaging technology developer - Says the US Centers for Medicare & Medicaid Services has established a new reimbursement code for Polarean's Xenoview or 'xenon XE 129' magnetic resonance imaging technology. Code "enables healthcare providers a path to bill for 'magnetic resonance imaging with [the] inhaled hyperpolarised xenon-129 contrast agent...including preparation and administration of agent'." Polarean expects to be informed of the new code's payment level "in the coming weeks".

Read more
3 Aug 2023 11:31

IN BRIEF: Polarean hails US FDA approval on Philips MRI configuration

Polarean Imaging PLC - London-based medical imaging technology company - Receives 510(k) clearance from the US Food & Drug Administration for its specialised magnetic resonance imaging chest coil. The coil may now include Philips 3.0T MRI scanners for the visualisation of the Xenon-129 nuclei.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.